Listen to the SC Launch CEO Podcast featuring MitoChem

Listen as Michael Voevodsky, president and CEO of MitoChem Therapeutics, discusses the history, challenges, and future of MitoChem.

Founded at the Medical University of South Carolina, MitoChem Therapeutics was started by two scientists who saw an opportunity to focus on developing treatments to address the effects of cellular and metabolic dysfunction in neurodegenerative conditions, specifically eye diseases. 

MitoChem Therapeutics became an SCRA Member Company in 2019 and received a $25,000 Academic Startup Grant. The company became an SC Launch Inc. Portfolio Company with a $200,000 investment in August of 2022. Listen to the podcast.

Unique Partnership Seeks to Advance Precision Medicine Options for Deadly GBM Brain Tumors

Neurosurgical medical device innovator NICO Corporation and Kiyatec Inc., an SC Launch Inc. Portfolio Company and leader in functional precision oncology, announced a partnership in glioma patient care to address the well-published unmet clinical need of obtaining better tissue to achieve greater accuracy in predicting tumor response to cancer targeted agents and chemotherapies. Read more.

SCRA instrumental in bringing Dash EV to South Carolina

Dash EV will set up its home base at 355 South Main St. in the Camperdown development in downtown Greenville and initially create at least 10 new jobs.

The family-owned micromobility company is known for its production of “Dash,” an electric and solar-charged car aimed at growing the carsharing industry at universities and in cities like Greenville and Clemson University. Read more.

NOV 1 @6:00 p.m

Founder Institute: Founder Night Out.

Learn more.

NOV 3-4

South Carolina Manufacturing Conference and Expo.

Learn more.

NOV 9 @10:00 a.m

SC Department of Commerce: International Trade Documentation Webinar. Learn more.

NOV 10 @3:00 p.m

Monthly TATT Chat. 

Learn more.

NOV 10 @5:00 p.m

SCBIO: Midlands Meet Up. Learn more.

DEC 8 @3:00 p.m

Monthly TATT Chat. 

Learn more.